414 related articles for article (PubMed ID: 28067625)
1. Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models.
Maasz G; Zrinyi Z; Reglodi D; Petrovics D; Rivnyak A; Kiss T; Jungling A; Tamas A; Pirger Z
Dis Model Mech; 2017 Feb; 10(2):127-139. PubMed ID: 28067625
[TBL] [Abstract][Full Text] [Related]
2. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
Reglodi D; Lubics A; Tamás A; Szalontay L; Lengvári I
Behav Brain Res; 2004 May; 151(1-2):303-12. PubMed ID: 15084446
[TBL] [Abstract][Full Text] [Related]
4. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model.
Lamine A; Létourneau M; Doan ND; Maucotel J; Couvineau A; Vaudry H; Chatenet D; Vaudry D; Fournier A
Neuropharmacology; 2016 Sep; 108():440-50. PubMed ID: 26006268
[TBL] [Abstract][Full Text] [Related]
5. Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats.
Reglödi D; Lubics A; Kiss P; Lengvári I; Gaszner B; Tóth G; Hegyi O; Tamás A
Neuropeptides; 2006 Aug; 40(4):265-74. PubMed ID: 16904179
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of PACAP and the PAC1 Receptor in the Basal Ganglia, Substantia Nigra and Centrally Projecting Edinger-Westphal Nucleus in the Rotenone model of Parkinson's Disease.
Fehér M; Márton Z; Szabó Á; Kocsa J; Kormos V; Hunyady Á; Kovács LÁ; Ujvári B; Berta G; Farkas J; Füredi N; Gaszner T; Pytel B; Reglődi D; Gaszner B
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511603
[TBL] [Abstract][Full Text] [Related]
7. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
8. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.
Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H
Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons.
Takei N; Skoglösa Y; Lindholm D
J Neurosci Res; 1998 Dec; 54(5):698-706. PubMed ID: 9843161
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease.
Reglódi D; Tamás A; Lengvári I; Toth G; Szalontay L; Lubics A
Ann N Y Acad Sci; 2006 Jul; 1070():518-24. PubMed ID: 16888218
[TBL] [Abstract][Full Text] [Related]
12. PACAP/PAC1-R activation contributes to hyperalgesia in 6-OHDA-induced Parkinson's disease model rats via promoting excitatory synaptic transmission of spinal dorsal horn neurons.
Dong LG; An MQ; Gu HY; Zhang LG; Zhang JB; Li CJ; Mao CJ; Wang F; Liu CF
Acta Pharmacol Sin; 2023 Dec; 44(12):2418-2431. PubMed ID: 37563446
[TBL] [Abstract][Full Text] [Related]
13. Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats.
Reglodi D; Tamás A; Lubics A; Szalontay L; Lengvári I
Regul Pept; 2004 Dec; 123(1-3):85-94. PubMed ID: 15518897
[TBL] [Abstract][Full Text] [Related]
14. The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson's Disease.
Thomas Broome S; Castorina A
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163768
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of PACAP against paraquat-induced oxidative stress in the Drosophila central nervous system.
Hajji K; Mteyrek A; Sun J; Cassar M; Mezghani S; Leprince J; Vaudry D; Masmoudi-Kouki O; Birman S
Hum Mol Genet; 2019 Jun; 28(11):1905-1918. PubMed ID: 30715303
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of pituitary adenylate cyclase activating polypeptide against neurotoxic agents.
Reglodi D; Tamas A; Jungling A; Vaczy A; Rivnyak A; Fulop BD; Szabo E; Lubics A; Atlasz T
Neurotoxicology; 2018 May; 66():185-194. PubMed ID: 29604313
[TBL] [Abstract][Full Text] [Related]
18. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
[TBL] [Abstract][Full Text] [Related]
19. Alterations of Nigral Dopamine Levels in Parkinson's Disease after Environmental Enrichment and PACAP Treatment in Aging Rats.
Jungling A; Reglodi D; Maasz G; Zrinyi Z; Schmidt J; Rivnyak A; Horvath G; Pirger Z; Tamas A
Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33429934
[TBL] [Abstract][Full Text] [Related]
20. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
